​

Protagenic Therapeutics Ownership | Who Owns Protagenic Therapeutics?

OverviewFinancialsChart

Protagenic Therapeutics Ownership Summary

Protagenic Therapeutics is owned by 3.69% institutional investors, 6.20% insiders, and 90.11% retail investors. Corecap advisors is the largest institutional shareholder, holding 0% of PTIX shares. Fidelity Extended Market Index is the top mutual fund, with 0.49% of its assets in Protagenic Therapeutics shares.

PTIX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockProtagenic Therapeutics3.69%6.20%90.11%
SectorHealthcare Stocks 244.37%12.11%-156.48%
IndustryBiotech Stocks 379.01%11.75%-290.76%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Corecap advisors---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Corecap advisors---

Top Buyers

HolderShares% AssetsChange
Corecap advisors---100.00

Top Sellers

HolderShares% AssetsChange
Corecap advisors---100.00

Sold Out

HolderChange
Corecap advisors-100.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20262-50.00%66,783-0.17%327.01%--100.00%--100.00%
Mar 31, 20264-66,900-3-4---
Dec 31, 20221525.00%611,4302.25%147.40%620.00%4300.00%
Sep 30, 2022129.09%597,947-1.11%137.06%525.00%1-50.00%
Jun 30, 202211-8.33%604,644-10.29%135.72%4-20.00%2-33.33%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Extended Market Index9.44K0.49%6.17K
Vanguard Institutional Extnd Mkt Idx Tr1.57K0.27%-715.00
Fidelity Nasdaq Composite Index1.26K0.07%-
Spartan Total Market Index Pool G808.000.04%591.00
Fidelity Series Total Market Index678.000.04%-
SSgA U.S. Extended Market Index Class I1.23K0.03%-
State St US Extended Mkt Indx NL Cl C88.000.01%-
Vanguard U.S. Eq Idx £ Acc84.000.01%-
NT Ext Equity Mkt Idx Fd - NL225.000.01%-
Northern Trust Extended Eq Market Idx177.000.01%-796.00

Recent Insider Transactions

DateNameRoleActivityValue
Aug 21, 2026ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFFBuy$13.00K
Aug 20, 2026ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFFBuy$9.81K
Aug 19, 2026ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFFBuy$945.00
Aug 11, 2026ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFFBuy$710.40
Aug 06, 2026ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFFBuy$150.70

Insider Transactions Trends

DateBuySell
2026 Q36-
2025 Q2--
2024 Q1--
2023 Q41-
2022 Q21-

PTIX Ownership FAQ

Who Owns Protagenic Therapeutics?

Protagenic Therapeutics shareholders are primarily institutional investors at 3.69%, followed by 6.20% insiders and 90.11% retail investors. The average institutional ownership in Protagenic Therapeutics's industry, Biotech Stocks , is 379.01%, which Protagenic Therapeutics falls below.

Does Blackrock own Protagenic Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Protagenic Therapeutics.

Who is Protagenic Therapeutics’s biggest shareholder by percentage of total assets invested?

Corecap advisors is Protagenic Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Protagenic Therapeutics shares, valued at 0$.

Who is the top mutual fund holder of Protagenic Therapeutics shares?

Fidelity Extended Market Index is the top mutual fund holder of Protagenic Therapeutics shares, with 0.49% of its total shares outstanding invested in 9.44K Protagenic Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools